All News
Pollution and Autoimmunity (7.12.2024)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Read ArticleICYMI: 2023 EULAR Non-pharmacological Management of Hip and Knee Osteoarthritis: 2023 update
EULAR has published the 2023 updated recommendations for the optimal non-pharmacological management of hip and knee osteoarthritis (OA).
Read Article![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
![](https://pbs.twimg.com/media/GRKmLEmXQAAEq0x.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg)
Janet Pope Janetbirdope ( View Tweet)
![](https://pbs.twimg.com/media/GQCHbOQWYAA0a_y.jpg)
![](https://pbs.twimg.com/media/GQBcnpvXMAAtgL1.jpg)
Can we withdraw treatment in post-menopausal osteoporosis?
Analysis of French claims data, found over half of women initiating oral bisphosphonates (BP) between 2015 and 2020 discontinued treatment for at least one year, which was associated with a 12% increase in fracture risk.
Read Article![](https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg)
Mrinalini Dey DrMiniDey ( View Tweet)
2023 EULAR classification criteria for hand osteoarthritis
A EULAR consensus group has established classification criteria for overall hand osteoarthritis (OA) and its subtypes (interphalangeal OA and thumb base OA).
The criteria require two mandatory criteria to be met:
![](https://pbs.twimg.com/media/GOmQuM5bkAAVBaW.jpg)
![](https://pbs.twimg.com/media/GOmQuM5bkAAVBaW.jpg)
The Window of Opportunity (5.24.2024)
Dr. Jack Cush reviews the journal reports and news from the past week on RheumNow.com. This week: blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis?
Read Article![](https://pbs.twimg.com/media/GOSfTdvXUAAL_ix.jpg)
![](https://pbs.twimg.com/media/GODrt12XcAAypPL.jpg)
Legal (Not So) Merry-Go-Round of Alendronate Atypical Fractures
Dr. Gregory Curfman, MD (Executive editor of JAMA) writes on the chronological legal progress of a lawsuit stemming from rare instances of atypical femoral fractures associated with bisphosphonate (alendronate) use.
Read ArticleAntacids can Diminish Bone Density
Proton pump inhibitors (PPIs), a specific class of antacid drugs, are among the most widely used medications of all. They are frequently prescribed to many groups of patients, including those with rheumatism.
Read ArticleConsensus Statements on Vitamin D
The “Controversies in Vitamin D” International Conference has published their proceedings on vitamin D metabolism, assessment, actions, and supplementation. Interestingly, optimal levels of 25-hydroxy vitamin D (25(OH)D) are still being debated.
Read Article![](https://pbs.twimg.com/media/GNgEBWsWsAAHBy4.jpg)
![](https://pbs.twimg.com/media/GNZ1wTwXIAAdwoR.jpg)